Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.
This page provides a focused view of news and announcements historically associated with Walgreens Boots Alliance, Inc. (formerly Nasdaq: WBA) and its related businesses, including Walgreens and Walgreens Specialty Pharmacy. Company communications highlight Walgreens as a U.S. retail pharmacy brand founded in 1901 that serves nearly 9 million customers and patients each day across approximately 8,500 stores in the U.S. and Puerto Rico, and Walgreens Boots Alliance as a pharmacy-led health and wellbeing enterprise formed through the combination of Walgreens and Alliance Boots.
News related to WBA and Walgreens has covered several key themes. One major area is corporate transactions and capital markets activity. In 2025, a series of announcements detailed the Agreement and Plan of Merger under which Blazing Star Merger Sub, Inc. merged with and into Walgreens Boots Alliance, Inc., resulting in the company becoming a wholly owned subsidiary of Blazing Star Parent, LLC, an affiliate of Sycamore Partners. Related releases described tender offers and consent solicitations for various series of Walgreens Boots Alliance and Walgreen Co. notes, pricing terms, extensions of expiration times and settlement dates, and the final results of these offers.
Another important news category involves the company’s transition from public to private ownership. A Form 8-K filed on August 28, 2025 describes the completion of the merger, the cash consideration and divested asset proceed rights received by shareholders, and the cessation of trading of WBA common stock and certain notes on Nasdaq. A subsequent Form 25 documents the removal of these securities from listing, and a Form 15 filed on September 8, 2025 terminates registration and suspends reporting obligations. Sycamore Partners separately announced the completion of its acquisition of Walgreens Boots Alliance, Inc. and its intention that Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD operate as standalone companies under private ownership.
Operational and healthcare-focused news also features prominently. Walgreens Specialty Pharmacy announced an expansion of its limited distribution drug network to 265 products, emphasizing its role in specialty medications for patients with rare, complex and chronic diseases and its independence from pharmacy benefit managers. Walgreens has also issued releases on vaccination services, including nationwide flu shot availability for individuals three years and older, walk-in and scheduled appointments, digital check-in features and incentives for myWalgreens members receiving vaccines.
Investors and observers using this news page can review historical coverage of WBA’s merger process, debt tender offers, governance and shareholder actions, as well as Walgreens’ specialty pharmacy initiatives and vaccination programs. For those tracking the evolution of the company, these articles collectively document WBA’s path from a publicly traded integrated healthcare and retail group to a privately held organization under Sycamore Partners, while also illustrating how Walgreens positions its pharmacies and specialty operations within the broader healthcare landscape.
Walgreens (Nasdaq: WBA) launched the myWalgreens Credit Card program in partnership with Synchrony Bank (NYSE: SYF). This program includes two innovative credit cards that reward personalized health and wellness choices, providing rewards at over 9,000 Walgreens locations and online. Cardholders can earn up to 10% in Walgreens Cash rewards on eligible purchases. The cards feature a digital-led experience for easy applications and seamless integration with the Walgreens app. This initiative expands Walgreens' financial services, aiming to enhance customer loyalty through unique health-focused rewards.
Walgreens Boots Alliance (WBA) and VillageMD have announced the opening of three Village Medical clinics in Orlando, with plans for seven additional locations by year-end. This initiative aims to enhance patient access to coordinated pharmacy and primary care services, addressing the health needs of over 13 million Floridians with chronic conditions. The project will create approximately 400 jobs, including 200 high-paying STEM positions. The clinics will offer diverse insurance options and telehealth services, promoting improved health outcomes for patients.
Walgreens has administered over 29 million COVID-19 vaccinations across the U.S., witnessing a more than 30% increase in demand in key areas. The rise in cases, particularly due to the Delta variant, has also led to a doubling of testing volumes. As a safety measure, Walgreens has reinstated face cover requirements for all employees and mandated that U.S. support office team members be fully vaccinated by September 30. The company remains committed to health and wellness amid the ongoing pandemic.
Lemonaid Health has expanded its services into the United Kingdom, partnering with Boots UK, the leading pharmacy retailer. This marks Lemonaid's first international venture after seven years of operation in the U.S., providing online doctor visits and medicine delivery. The partnership allows Boots to offer its customers quick access to prescription-only medicines via online consultations. Services start at £15, and patients can also earn Boots Advantage Card points. The collaboration is expected to enhance patient care and accessibility in the U.K.
Lemonaid Health has announced its expansion into the United Kingdom, partnering with Boots UK, the largest pharmacy-led health and beauty retailer. This launch marks Lemonaid's first international venture following its success in the U.S. The service offers quick online consultations for prescription-only medication, with prices starting at £15. Patients can access their prescriptions via Boots pharmacies or home delivery. The partnership aims to enhance healthcare accessibility and improve patient outcomes through innovative telemedicine services.
Huggies and Walgreens have launched their fifth consecutive initiative to combat diaper need in America, with a goal of donating up to 1 million diapers through August 31, 2021. Customers can contribute by purchasing Huggies diapers at Walgreens, triggering a donation of a day's worth of diapers for each pack sold. Additionally, the #HuggiesStrollerSelfie Challenge encourages social media participation, with each selfie shared resulting in a $1 donation, up to $5,000. This effort aims to support families in need and raise awareness about diaper need, impacting one in three American families.
Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD announced plans to open new Village Medical at Walgreens locations in Indiana, targeting communities including Merrillville, Griffith, Portage, and South Bend. The initiative aims to fulfill a commitment to open at least 600 locations across over 30 U.S. markets within four years, part of a $1 billion investment effort launched in January 2021. This partnership seeks to enhance healthcare access through a coordinated care model involving primary care physicians and Walgreens pharmacy services.
Walgreens Boots Alliance (Nasdaq: WBA) announced a quarterly dividend of 47.75 cents per share, reflecting a 2.1% increase. This dividend will be payable on September 10, 2021 to stockholders of record as of August 20, 2021, raising the annual rate from $1.87 to $1.91 per share. The company has maintained dividend payments for 355 consecutive quarters and increased dividends for 46 consecutive years, showcasing consistent financial stability.
Walgreens Boots Alliance (Nasdaq: WBA) and VillageMD will open 29 new Village Medical at Walgreens practices in Houston, Austin, and El Paso this year, aiming for at least 600 locations in over 30 U.S. markets within four years. This initiative is part of a $1 billion investment to enhance healthcare access through integrated services. The expansion targets over 825,000 patients aged 65+ in Texas, emphasizing the need for quality care. The collaborative model allows patients to benefit from coordinated pharmacy and primary care services, addressing chronic health issues effectively.
Walgreens has expanded its same day prescription delivery service to nearly all store locations, making it available seven days a week. This initiative aims to enhance customer convenience, allowing patients to manage prescriptions from home and receive medications within hours. Customers can enroll by texting 'Join Rx' to 21525. Delivery fees vary by location, and the service is not available in California. This enhancement follows Walgreens’ previous launch of same day delivery for over 24,000 retail products, reinforcing their commitment to a seamless omnichannel experience.